NEW YORK, July 6 – The proposed acquisition of Aurora Biosciences by Vertex Pharmaceuticals has cleared a significant hurdle with the deal being cleared by the United States Federal Trade Commission, the companies announced Friday.

The FTC granted clearance under the Hart-Scott-Rodino Antitrust Improvements Act. The deal is still subject to approval by the companies’ shareholders at meetings scheduled for July 18.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.